{"id":"W2801845647","doi":"10.1186/s12955-018-0892-0","title":"Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER)","year":2018,"lang":"en","type":"article","venue":"Health and Quality of Life Outcomes","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Sherbrooke; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma","keywords":"Overactive bladder; Tolerability; Tolterodine; Medicine; Mirabegron; Crossover study; Randomized controlled trial; Urology; Quality of life (healthcare); Patient satisfaction; Internal medicine; Placebo; Adverse effect; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001157921,0.0003641749,0.001943008,0.0003496548,0.000126808,0.00004026245,0.00005302147,0.00007510003,0.00003463604],"category_scores_gemma":[0.0002988874,0.0002167527,0.00006350375,0.0003201882,0.0004626817,0.0002676074,0.00007552671,0.0003512093,0.000001429803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001140247,"about_ca_system_score_gemma":0.0003215843,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00943024,"about_ca_topic_score_gemma":0.004008247,"domain_scores_codex":[0.9962628,0.0006088062,0.001233085,0.0006243048,0.0007193603,0.0005516051],"domain_scores_gemma":[0.9979332,0.0004030323,0.0004934229,0.0003494252,0.0003657909,0.0004551443],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3925554,0.002760385,0.5955122,0.0002076966,0.0003385124,0.00001088937,0.008356419,3.092389e-7,0.000001248727,0.000006988947,0.000003586784,0.0002463242],"study_design_scores_gemma":[0.3980258,0.004948366,0.5948042,0.00009509017,0.00003744584,0.000001678892,0.001920773,0.00000934724,0.00001297032,0.00000375217,0.000004285178,0.0001363095],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911824,0.0001874499,0.000004017712,0.000791657,0.00003130373,0.00755476,0.00003373934,0.00002508462,0.0001895682],"genre_scores_gemma":[0.9987144,0.00004105543,0.000194996,0.0005938722,0.00001367334,0.0002235842,0.00004418921,0.00002986049,0.0001443053],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007532045,"threshold_uncertainty_score":0.997166,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06162903128490681,"score_gpt":0.3966537868859398,"score_spread":0.335024755601033,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}